Skip to content

PATH Clinical Trial – Now Recruiting!

PATH_Logo

The PATH Study is exploring the use of an oral medication called pomalidomide for the treatment of nosebleeds in HHT at several research centers across the United States. Find centers and check your eligibility.

Scroll To Top